Sarepta Therapeutics, Inc. (SRPT)
17.55
-1.13
(-6.05%)
USD |
NASDAQ |
May 15, 16:00
17.90
+0.35
(+1.99%)
After-Hours: 20:00
Sarepta Therapeutics Total Liabilities (Quarterly) : 1.674B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | 3.050B |
| Keros Therapeutics, Inc. | 26.66M |
| REGENXBIO, Inc. | 320.81M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Cytokinetics, Inc. | 2.100B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.179B |
| Shareholders Equity (Quarterly) | 1.505B |
| Debt to Equity Ratio | 0.6888 |
| Current Ratio | 4.628 |
| Net Debt Paydown Yield | 2.67% |